Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Evidence for a stepwise program of extrathymic T cell development within the human tonsil
Susan McClory, … , Gerard Nuovo, Michael A. Caligiuri
Susan McClory, … , Gerard Nuovo, Michael A. Caligiuri
Published March 1, 2012
Citation Information: J Clin Invest. 2012;122(4):1403-1415. https://doi.org/10.1172/JCI46125.
View: Text | PDF
Research Article Immunology

Evidence for a stepwise program of extrathymic T cell development within the human tonsil

  • Text
  • PDF
Abstract

The development of a broad repertoire of T cells, which is essential for effective immune function, occurs in the thymus. Although some data suggest that T cell development can occur extrathymically, many researchers remain skeptical that extrathymic T cell development has an important role in generating the T cell repertoire in healthy individuals. However, it may be important in the setting of poor thymic function or congenital deficit and in the context of autoimmunity, cancer, or regenerative medicine. Here, we report evidence that a stepwise program of T cell development occurs within the human tonsil. We identified 5 tonsillar T cell developmental intermediates: (a) CD34+CD38dimLin– cells, which resemble multipotent progenitors in the bone marrow and thymus; (b) more mature CD34+CD38brightLin– cells; (c) CD34+CD1a+CD11c– cells, which resemble committed T cell lineage precursors in the thymus; (d) CD34–CD1a+CD3–CD11c– cells, which resemble CD4+CD8+ double-positive T cells in the thymus; and (e) CD34–CD1a+CD3+CD11c– cells. The phenotype of each subset closely resembled that of its thymic counterpart. The last 4 populations expressed RAG1 and PTCRA, genes required for TCR rearrangement, and all 5 subsets were capable of ex vivo T cell differentiation. TdT+ cells found within the tonsillar fibrous scaffold expressed CD34 and/or CD1a, indicating that this distinct anatomic region contributes to pre–T cell development, as does the subcapsular region of the thymus. Thus, we provide evidence of a role for the human tonsil in a comprehensive program of extrathymic T cell development.

Authors

Susan McClory, Tiffany Hughes, Aharon G. Freud, Edward L. Briercheck, Chelsea Martin, Anthony J. Trimboli, Jianhua Yu, Xiaoli Zhang, Gustavo Leone, Gerard Nuovo, Michael A. Caligiuri

×

Figure 1

The human tonsil contains CD34+CD38dimLin–, CD34+CD38brightLin–, and CD34+CD1a+CD11c– cells.

Options: View larger image (or click on image) Download as PowerPoint
The human tonsil contains CD34+CD38dimLin–, CD34+CD38brightLin–, and CD3...
(A) Expression of CD34 and lineage markers (CD11c, BDCA-2, CD117, CD161, CD19, CD3, CD1a) on CD34-enriched tonsillar cells (left). Total lymphocytes were gated on Lin– events and analyzed for their expression of CD34 and CD38 (right). The number above each gate indicates the mean percentage of CD34+ cells falling within that gate. (B) Expression of CD1a on CD34-enriched tonsillar cells (left). The number above each gate indicates the mean percentage of CD34+ cells falling within that gate. Events were gated on CD34+CD1a+ cells and analyzed for their coexpression of CD10 and CD11c (right). The number within the top left and bottom right quadrants represents the mean percentage of CD34+CD1a+ cells that are defined as either CD11c+ or CD10+, respectively. (C) The percentage of CD34+ cells that are defined as CD34+CD1a+CD11c– in 4 representative human pediatric tonsils. Plots are gated on total CD34+ cells. Numbers in the bottom right quadrant indicate the percentage of CD34+ cells that are CD1a+CD11c– in that particular donor. All data are from a representative tonsil of (A) 3, (B) 4, or (C) 24 individual donors.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts